Insider Trading Alert - TYL, SWHC And ZLTQ Traded By Insiders - TheStreet

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Oct. 30, 2014, 42 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $57.29 to $161,511,350.00.

Highlighted Stocks Traded by Insiders:

Tyler Technologies (TYL) - FREE Research Report

Brattain Donald R, who is Director at Tyler Technologies, sold 5,500 shares at $102.73 on Oct. 30, 2014. Following this transaction, the Director owned 16,000 shares meaning that the stake was reduced by 25.58% with the 5,500-share transaction.

The shares most recently traded at $112.37, up $9.64, or 8.58% since the insider transaction. Historical insider transactions for Tyler Technologies go as follows:

  • 4-Week # shares sold: 7,000
  • 12-Week # shares sold: 17,000
  • 24-Week # shares sold: 47,000

The average volume for Tyler Technologies has been 211,600 shares per day over the past 30 days. Tyler Technologies has a market cap of $3.5 billion and is part of the technology sector and computer software & services industry. Shares are up 8.12% year-to-date as of the close of trading on Thursday.

Tyler Technologies, Inc. provides integrated information management solutions and services for the public sector with a focus on local governments in the United States and internationally. The company has a P/E ratio of 70.0. Currently, there are 4 analysts who rate Tyler Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on TYL - FREE

TheStreet Quant Ratings

rates Tyler Technologies as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, robust revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full

Tyler Technologies Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Smith & Wesson (SWHC) - FREE Research Report

Buchanan Jeffrey D, who is Exec. VP, CFO & Treasurer at Smith & Wesson, bought 5,000 shares at $10.10 on Oct. 30, 2014. Following this transaction, the Exec. VP, CFO & Treasurer owned 136,182 shares meaning that the stake was boosted by 3.81% with the 5,000-share transaction.

The shares most recently traded at $10.22, up $0.12, or 1.17% since the insider transaction. Historical insider transactions for Smith & Wesson go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 10,000

The average volume for Smith & Wesson has been 1.5 million shares per day over the past 30 days. Smith & Wesson has a market cap of $565.9 million and is part of the industrial goods sector and aerospace/defense industry. Shares are down 25.65% year-to-date as of the close of trading on Thursday.

Smith & Wesson Holding Corporation manufactures and sells firearm products in the United States and internationally. The company has a P/E ratio of 8.0. Currently, there are 6 analysts who rate Smith & Wesson a buy, 1 analyst rates it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on SWHC - FREE

TheStreet Quant Ratings

rates Smith & Wesson as a

buy

. The company's strengths can be seen in multiple areas, such as its notable return on equity, attractive valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Smith & Wesson Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

ZELTIQ Aesthetics (ZLTQ) - FREE Research Report

Foley Mark J, who is President and CEO at ZELTIQ Aesthetics, sold 25,000 shares at $25.81 on Oct. 30, 2014. Following this transaction, the President and CEO owned 580,033 shares meaning that the stake was reduced by 4.13% with the 25,000-share transaction.

Garcia Sergio, who is Senior VP, GC & Secretary at ZELTIQ Aesthetics, sold 500 shares at $25.97 on Oct. 30, 2014. Following this transaction, the Senior VP, GC & Secretary owned 89,163 shares meaning that the stake was reduced by 0.56% with the 500-share transaction.

The shares most recently traded at $22.89, down $3.08, or 13.44% since the insider transaction. Historical insider transactions for ZELTIQ Aesthetics go as follows:

  • 4-Week # shares sold: 8,023
  • 12-Week # shares sold: 33,828
  • 24-Week # shares sold: 72,947

The average volume for ZELTIQ Aesthetics has been 746,500 shares per day over the past 30 days. ZELTIQ Aesthetics has a market cap of $833.1 million and is part of the health care sector and health services industry. Shares are up 17.4% year-to-date as of the close of trading on Wednesday.

ZELTIQ Aesthetics, Inc., a medical technology company, is engaged in developing and commercializing non-invasive products for the selective reduction of fat. It offers CoolSculpting system, which utilizes proprietary controlled-cooling technology to selectively reduce stubborn fat bulges. Currently, there are 5 analysts who rate ZELTIQ Aesthetics a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on ZLTQ - FREE

TheStreet Quant Ratings

rates ZELTIQ Aesthetics as a

sell

. The area that we feel has been the company's primary weakness has been its disappointing return on equity. Get the full

ZELTIQ Aesthetics Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null